This week we discuss the BICAR-ICU trial from France. In patients who are critically ill with metabolic acidosis, does giving bicarb help improve survival? More importantly, does it help with kidney outcomes? Join us to discuss
This week, we will discuss the CREDENCE trial, simply the most important nephrology trial in a generation.
This week we look at the treatment of depression in hemodialysis patients. It is cognitive behavorial therapy versus sertraline.